Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 141.40
+0.10 (0.07%)
Oct 8, 2025, 2:44 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 130.16 billion as of October 7, 2025. Its market cap has increased by 167.00% in one year.
Market Cap
130.16B
Enterprise Value
127.22B
Revenue
2.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
141.40
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 130.16B, an increase of 601.88%. That is a compound annual growth rate of 42.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 130.16B | 138.90% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 295.17B |
| Hansoh Pharmaceutical Group Company | 234.53B |
| JD Health International | 207.30B |
| Innovent Biologics | 172.13B |
| WuXi Biologics | 170.68B |
| Sino Biopharmaceutical | 148.38B |
| Sichuan Kelun-Biotech Biopharmaceutical | 130.93B |
| CSPC Pharmaceutical Group | 110.90B |